Abstract
We have demonstrated that an alternative C5a receptor (C5aR) ligand, the homodimer of ribosomal protein S19 (RP S19), contains a unique C-terminus (I134–H145) that is distinct from the moieties involved in the C5a–C5aR interaction. To examine the role of I134–H145 in the ligand–C5aR interaction, we connected this peptide to the C-terminus of C5a (C5a/RP S19) and found that it endowed the second binding moiety of RP S19 (L131DR) with a relatively higher binding affinity to the C5aR on a human mast cell line, HMC-1. In contrast to the C5aR, the second C5aR C5L2 worked as a decoy receptor. As a result, the mitogen-activated protein kinase (MAPK) downstream of the Gi protein exchanged extracellular-signal regulated kinase for p38MAPK. This alternative p38MAPK activation could be pharmacologically suppressed not only by the downregulation of phosphoinositide 3-kinase (PI3K) by LY294002, but also by the over-activation of protein kinase C by phorbol 12-myristate 13-acetate. The activation was reproduced upon C5a–C5aR interaction by a simultaneous suppression of PI3K and phospholipase C with LY294002 and U73122 at low concentrations. Moreover, p38MAPK phosphorylation upstream of the pertussis toxin-dependent extracellular Ca2+ entry was also suppressed by high concentrations of MgCl2, which blocks melastatin-type transient receptor potential Ca2+ channels (TRPMs). The active conformation of C5aR upon the ligation by C5a, at least on HMC-1 cells, is changed by the additional interaction of the I134–H145 peptide, which seems to guide the alternative activation of p38MAPK. This activation is then amplified by a novel positive feedback loop between p38MAPK and TRPM.
Similar content being viewed by others
References
Gerard NP, Bao L, Xiao-Ping H, Eddy RL Jr, Shows TB, Gerard C (1993) Human chemotaxis receptor genes cluster at 19q13.3–13.4. Characterization of the human C5a receptor gene. Biochemistry 32:1243–1250
Monk PN, Scola A-M, Madala P, Fairlie DP (2007) Function, structure and therapeutic potential of complement C5a receptors. Br J Pharm 152:429–448
Goldsmith ZG, Dhanasekaran DN (2007) G Protein regulation of MAPK networks. Oncogene 26:3122–3142
Siciliano SJ, Rollins TE, DeMartino J, Konteatis Z, Malkowitz L, Van RG, Bondy S, Rosen H, Springer MS (1994) Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc Natl Acad Sci USA 91:1214–1218
Yamamoto T (2007) Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes. Pathol Int 57:1–11
Nishiura H, Shibuya Y, Matsubara S, Tanase S, Kambara T, Yamamoto T (1996) Monocyte chemotactic factor in rheumatoid arthritis synovial tissue: probably a cross-linked derivative of S19 ribosomal protein. J Biol Chem 271:878–882
Shrestha A, Shi L, Tanase S, Tsukamoto M, Nishino N, Tokita K, Yamamoto T (2004) Bacterial chaperone protein, Skp, induces leukocyte chemotaxis via C5a receptor. Am J Pathol 164:763–772
Nishiura H, Tanase S, Shibuya Y, Nishimura T, Yamamoto T (1999) Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest 79:915–923
Horino K, Nishiura H, Ohsako T, Shibuya Y, Hiraoka T, Kitamura N, Yamamoto T (1998) A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest 78:603–617
Nishimura T, Horino K, Nishiura H, Shibuya Y, Hiraoka T, Tanase S, Yamamoto T (2001) Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J Biochem 129:445–454
Shrestha A, Horino K, Nishiura H, Yamamoto T (1999) Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab Invest 79:1629–1642
Shibuya Y, Shiokawa M, Nishiura H, Nishimura T, Nishino N, Okabe H, Takagi K, Yamamoto T (2001) Identification of receptor binding sites of monocyte chemotactic S19 ribosomal protein dimer. Am J Pathol 159:2293–2301
Shrestha A, Shiokawa M, Nishimura T, Nishiura H, Tanaka Y, Nishino N, Shibuya Y, Yamamoto T (2003) Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor. Am J Pathol 162:1381–1388
Nishiura H, Shibuya Y, Yamamoto T (1998) S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab Invest 78:1615–1623
Revollo I, Nishiura H, Shibuya Y, Oda Y, Nishino N, Yamamoto T (2005) Agonist and antagonist dual effect of the cross-linked ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes. Inflamm Res 54:82–90
Fukuoka Y, Ember JA, Yasui A, Hugli TE (1998) Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors. Int Immunol 10:275–283
Umeda Y, Shibuya Y, Semba U, Tokita K, Nishino N, Yamamoto T (2004) Guinea pig ribosomal protein as precursor of C5a receptor-directed monocyte-selected leukocyte chemotactic factor. Inflamm Res 53:623–630
Oda Y, Tokita K, Ota Y, Li Y, Taniguchi K, Nishino N, Takagi K, Yamamoto T, Nishiura H (2008) Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J Biochem 144:371–381
Nishiura H, Tanase S, Shibuya Y, Futa N, Sakamoto T, Higginbottom A, Monk P, Zwirner J, Yamamoto T (2005) S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor. J Cell Biochem 94:540–553
Nishiura H, Nonaka H, Revollo SI, Semba U, Li Y, Ota Y, Irie A, Harada K, Kehrl HJ, Yamamoto T (2009) Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase. Lab Invest 89:676–694
Gonzalez VM, Fuertes MA, Alonso C, Perez JM (2006) Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells. J Immunol 177:3439–3447
Harteneck C, Frenzel H, Kraft R (2007) N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blocker. Cardiovasc Drug Rev 25:61–75
Sumichika H, Sakata K, Sato N, Takeshita S, Ishibuchi S, Nakamura M, Kamahori T, Ehara S, Itoh K, Ohtsuka T, Ohbora T, Mishina T, Komatsu H, Naka Y (2002) Identification of a potent and orally active non-peptide C5a receptor antagonist. J Biol Chem 277:49403–49407
Robert SA, Dennis L, James JF, Anthony JJ, Mark AT, Wilfried B, Britta S, Andreas K, Karl FE, Russell DC, Anthony CS JPH, Gerald M, Keith WW, Jerry LA, William EB, David CU, Ruth RO, Alison MB, Henry MS (2001) Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol 166:6341–6348
Konteatis ZD, Siciliano SJ, Van-Riper G, Molineaux CJ, Pandya S, Fischer P, Rosen H, Mumford RA, Springer MS (1994) Development of C5a receptor antagonists: differential loss of functional responses. J Immunol 153:4200–4205
Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, Fairlie DP, Taylor SM (1999) Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem 42:1965–1974
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Kyhse-Andersen J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10:203–209
Shore PA (1971) The chemical determination of histamine. Methods Biochem Anal 89–97
Matsubara S, Yamamoto T, Tsuruta T, Takagi K, Kambara T (1991) Complement C4-derived monocyte-directed chemotaxis-inhibitory factor: a molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am J Pathol 138:1279–1291
Falk W, Goldwin RH, Leonard EJ (1980) A 48 well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239–247
Tokita K, Yamamoto T (2004) Differential role of neutrophils and monocytes during subcutaneous plasma extravasation. Lab Invest 84:1174–1184
Luca M (2006) Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anti Cancer Drug Discov 1:105–119
Skokowa J, Ali SR, Felda O, Kumar V, Konrad S, Shushakova N (2005) Macrophages induce the inflammatory response in the pulmonary arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J Immunol 174:3041–3050
Elorza A, Sarnago S, Mayor F Jr (2000) Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol Pharmacol 57:778–783
Schaeffer V, Cuschieri J, Garcia I, Knoll M, Billgren J, Jelacic S, Bulger E, Maier R (2007) The priming effect of C5a on monocytes is predominantly mediated by the p38 MAPK pathway. Shock 27:623–630
Mehta KD, Miller L (1999) Inhibition of stress-activated p38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression. Trends Cardiovasc Med 9:201–205
Rubinfeld H, Seger R (2005) The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31:151–174
Hilal-Dandan R, Means CK, Gustafsson AB, Morissette MR, Adams JW, Brunton LL, Heller Brown J (2004) Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. J Mol Cell Cardiol 36:481–493
Peregrin S, Jurado-Pueyo M, Campos MP, Sanz-Moreno V, Ruiz-Gomez A, Crespo P, Mayor F Jr, Murga C (2006) Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Current Biol 16:2042–2047
Markus H, Reinold P (1992) Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355:353–356
Pedersen SF, Owsianik G, Nilius B (2005) TRP channels: an overview. Cell Calcium 38:233–252
Stacey SW, Peter ND (2006) Signaling pathways mediating chemotaxis in the social amoeba, Dictyostelium discoideum. Eur J Cell Biol 85:897–904
Guo NH, Zabrenetzky SV, Chandrasekaran L, Sipes MJ, Lawler J, Krutzsch CH, Roberts DD (1998) Differential roles of protein kinase c and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1. Cancer Res 58:3154–3162
Wakasugi K, Schimmel P (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147–151
Peter C, Waibel M, Radu CG, Yang LV, Witte ON, Schulze-Osthoff K, Wesselborg S, Lauber K (2008) Migration to apoptotic “find-me” signals is mediated via the phagocyte receptor G2A. J Biol Chem 283:5296–5305
Touyz RM (2008) Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 294:1103–1118
Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M (2003) A key role for TRPM7 channels in anoxic neuronal death. Cell 115:863–877
Zhang IW, Hirschler-Laszkiewicz Q, Tong K, Conrad SC, Sun L, Penn DL, Barber R, Stahl DJ, Carey JY, Cheung BA (2006) TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage. Am J Physiol Cell Physiol 290:1146–1159
Oike H, Wakamori M, Mori Y, Nakanishi H, Taguchi R, Misaka T, Matsumoto I, Abe K (2006) Arachidonic acid can function as a signaling modulator by activating the TRPM5 cation channel in taste receptor cells. Biochim Biophys Acta 1761:1078–1084
Andersson DA, Nash M, Bevan S (2007) Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids. J Neurosci 27:3347–3355
Zweifach A, Lewis RS (1995) Rapid inactivation of depletion-activated calcium current (ICRAC) due to local calcium feedback. J Gen Physiol 105:209–226
Cain SA, Monk PN (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem 277:7165–7169
Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN (2003) The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J Biol Chem 278:11123–11129
Gerard NP, Lu B, Liu P, Craig S, Fujiwara Y, Okinaga S, Gerard C (2005) An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 280:39677–39680
Otto M, Hawlisch H, Monk PN, Müller M, Klos A, Karp CL, Köhl J (2004) C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J Biol Chem 279:142–151
Gougeon ML, Piacentini M (2009) New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14:501–508
Acknowledgments
This work was supported by Japan Science and Technology Agency (project code: 09801156) and a Grant-in Aid for Scientific Research (C) (KAKENHI 22590362) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nishiura, H., Tokita, K., Li, Y. et al. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells. Apoptosis 15, 966–981 (2010). https://doi.org/10.1007/s10495-010-0511-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-010-0511-y